Si-Bone (SIBN) EBIT Margin (2017 - 2026)
Si-Bone's quarterly EBIT Margin came in at 9.68% in Q1 2026, up 613.0% year-on-year from 1.36% in Q1 2025, and down 121.57% quarter-over-quarter from 4.37% in Q4 2025.
Si-Bone has reported EBIT Margin for 10 years, with the latest figure at 9.68% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 613.0% year-over-year to 9.68%; the trailing twelve-month figure through Mar 2026 stood at 9.67% (up 770.0% YoY), and the FY2025 full-year result was 11.11%, up 997.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 9.68%, down from 4.37% in the prior quarter.
- The five-year high for EBIT Margin was 4.37% in Q4 2025, with the low at 75.17% in Q1 2022.
- Average EBIT Margin over 5 years is 29.98%, with a median of 31.8% recorded in 2024.
- Year-over-year, EBIT Margin slumped 1855 bps in 2022 and jumped 4065 bps in 2023.
- Tracing SIBN's EBIT Margin over 5 years: stood at 35.35% in 2022, then increased by 9 bps to 32.18% in 2023, then surged by 65 bps to 11.21% in 2024, then jumped by 61 bps to 4.37% in 2025, then plunged by 122 bps to 9.68% in 2026.
- The last three EBIT Margin figures came in at 9.68% (Q1 2026), 4.37% (Q4 2025), and 11.06% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | -9.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.68% |
| Dec 31, 2025 | -4.37% |
| Sep 30, 2025 | -11.06% |
| Jun 30, 2025 | -14.40% |
| Mar 31, 2025 | -15.82% |
| Dec 31, 2024 | -11.21% |
| Sep 30, 2024 | -18.92% |
| Jun 30, 2024 | -25.21% |
| Mar 31, 2024 | -31.80% |
| Dec 31, 2023 | -32.18% |
| Sep 30, 2023 | -32.84% |
| Jun 30, 2023 | -35.92% |
| Mar 31, 2023 | -34.53% |
| Dec 31, 2022 | -35.35% |
| Sep 30, 2022 | -51.32% |
| Jun 30, 2022 | -69.89% |
| Mar 31, 2022 | -75.17% |
| Dec 31, 2021 | -55.22% |
| Sep 30, 2021 | -59.23% |
| Jun 30, 2021 | -58.42% |
| Mar 31, 2021 | -56.62% |
| Dec 31, 2020 | -35.54% |
| Sep 30, 2020 | -42.58% |
| Jun 30, 2020 | -72.17% |
| Mar 31, 2020 | -70.64% |
| Dec 31, 2019 | -42.83% |
| Sep 30, 2019 | -65.39% |
| Jun 30, 2019 | -49.87% |
| Mar 31, 2019 | -58.70% |
| Dec 31, 2018 | -27.57% |
| Sep 30, 2018 | -22.75% |
| Jun 30, 2018 | -12.42% |
| Mar 31, 2018 | -22.95% |
| Dec 31, 2017 | -11.92% |
| Sep 30, 2017 | -43.13% |